{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:01:16Z","timestamp":1784955676425,"version":"3.55.0"},"reference-count":20,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.7883\/yoken.jjid.2025.071","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:08:07Z","timestamp":1764281287000},"page":"143-149","source":"Crossref","is-referenced-by-count":0,"title":["Genome-Epidemiological and Seroepidemiological Study of the COVID-19 Cluster in a Nursing Home"],"prefix":"10.7883","volume":"79","author":[{"given":"Kei","family":"Fukuyama","sequence":"first","affiliation":[{"name":"Department of Virology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinuko","family":"Kamiyoshi","sequence":"additional","affiliation":[{"name":"Department of Research Planning, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masae","family":"Itamochi","sequence":"additional","affiliation":[{"name":"Department of Virology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yazawa","sequence":"additional","affiliation":[{"name":"Department of Virology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Research Planning, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Shinbo","sequence":"additional","affiliation":[{"name":"Department of Research Planning, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Virology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Saga","sequence":"additional","affiliation":[{"name":"Department of Virology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Virology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naobumi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Pathogen Genomics Center, National Institute of Infectious Diseases, JIHS, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Pathogen Genomics Center, National Institute of Infectious Diseases, JIHS, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Oishi","sequence":"additional","affiliation":[{"name":"Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tani","sequence":"additional","affiliation":[{"name":"Department of Virology, Toyama Institute of Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.","DOI":"10.1001\/jama.2020.1585"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-733.","DOI":"10.1056\/NEJMoa2001017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Vallee A. Geoepidemiological perspective on COVID-19 pandemic review, an insight into the global impact. Front Public Health. 2023;11:1242891.","DOI":"10.3389\/fpubh.2023.1242891"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Imamura T, Ko YK, Furuse Y, et al. Epidemiological factors associated with COVID-19 clusters in medical and social welfare facilities. Jpn J Infect Dis. 2022;75:281-287.","DOI":"10.7883\/yoken.JJID.2021.288"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shimizu K, Maeda H, Sando E, et al. Epidemiology of SARS-CoV-2 infection in nursing facilities and the impact of their clusters in a Japanese core city. J Infect Chemother. 2022;28:955-961.","DOI":"10.1016\/j.jiac.2022.04.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Furuse Y, Sando E, Tsuchiya N, et al. Clusters of coronavirus disease in communities, Japan, January-April 2020. Emerg Infect Dis. 2020;26:2176-2179.","DOI":"10.3201\/eid2609.202272"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lartigau M, Ouattara E, Tumiotto C, et al. Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France. J Clin Virol. 2022;149:105134.","DOI":"10.1016\/j.jcv.2022.105134"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wagatsuma K, Yoshioka S, Yamazaki S, et al. Assessing the pre-vaccination anti-SARS-CoV-2 IgG seroprevalence among residents and staff in nursing home in Niigata, Japan, November 2020. Viruses. 2022;14.","DOI":"10.3390\/v14112581"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sasanami M, Kayano T, Nishiura H. The number of COVID-19 clusters in healthcare and elderly care facilities averted by vaccination of healthcare workers in Japan, February-June 2021. Math Biosci Eng. 2022;19:2762-2773.","DOI":"10.3934\/mbe.2022126"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kawano-Sugaya T, Yatsu K, Sekizuka T, et al. Haplotype explorer: an infection cluster visualization tool for spatiotemporal dissection of the COVID-19 pandemic. G3 (Bethesda). 2021;11.","DOI":"10.1093\/g3journal\/jkab126"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Forster P, Forster L, Renfrew C, et al. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020;117:9241-9243.","DOI":"10.1073\/pnas.2004999117"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Khare S, Gurry C, Freitas L, et al. GISAID's role in pandemic response. China CDC Wkly. 2021;3:1049-1051.","DOI":"10.46234\/ccdcw2021.255"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Itamochi M, Yazawa S, Inasaki N, et al. Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort. Vaccine. 2023;41:2234-2242.","DOI":"10.1016\/j.vaccine.2023.02.068"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tani H, Kimura M, Tan L, et al. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Virol J. 2021;18:16.","DOI":"10.1186\/s12985-021-01490-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kawasuji H, Morinaga Y, Tani H, et al. Age-dependent reduction in neutralization against Alpha and Beta variants of BNT162b2 SARS-CoV-2 vaccine-induced immunity. Microbiol Spectr. 2021;9:e0056121.","DOI":"10.1128\/Spectrum.00561-21"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Morinaga Y, Tani H, Terasaki Y, et al. Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of antibodies to emerging variants. Microbiol Spectr. 2021;9:e0056021.","DOI":"10.1128\/Spectrum.00560-21"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tani H, Inasaki N, Yazawa S, et al. Neutralizing antibody levels and epidemiological characteristics of patients with breakthrough COVID-19 infection in Toyama, Japan. Jpn J Infect Dis. 2023;76:319-322.","DOI":"10.7883\/yoken.JJID.2023.100"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Koutsakos M, Reynaldi A, Lee WS, et al. SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses. Immunity. 2023;56:879-892 e4.","DOI":"10.1016\/j.immuni.2023.02.017"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Levine-Tiefenbrun M, Yelin I, Alapi H, et al. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nat Med. 2021;27:2108-2110.","DOI":"10.1038\/s41591-021-01575-4"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/79\/4\/79_JJID.2025.071\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:17:06Z","timestamp":1784953026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/79\/4\/79_JJID.2025.071\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2025.071","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"JJID.2025.071"}}